1 邵肖梅,叶鸿瑁,邱小汕.实用新生儿学.4版.北京:人民卫生出版社,2011:299-306.
2 Stanley I,Mei Chung,John K,et al.An evidence-based review of important issues concerning neonatal hyperbilirubinemia.Pediatrics,2004,1:130-153.
3 Byington CL,Reynolds CC,Korgenski K,et al.Costs and infant outcomes after implementation of a care process model for febrile infants.Pediatrics,2012,130:e16-e24.
4 Vople D,Harrison S,Damian F,et al.Improving timeliness of antibiotic delivery for patients with fever and suspected neutropenia in a pediatric emergency department.Pediatrics,2012,130:e201-e210.
5 Wolff M,Schinasi DA,Lavelle J,et al.Management of neonates with hyperbilirubinemia:improving timeliness of care using a clinical pathway.Pediatrics,2012,130:1688-1694.
6 Rotter T,Kinsman L,James E,et al.The effects of clinical pathways on professional practice,patient outcomes,length of stay,and hospital costs:Cochrane systematic review and meta-analysis.Eval Health Prof,2012,35:3-27.
7 关智勇,萧旗坚,刘清,等.儿科单病种管理的临床路径应用评价.华中科技大学学报(医学版),2014,43:102-105.
8 杨丽莎,何华云,陈新红,等.临床路径在新生儿ABO 血型不合溶血病换血治疗中应用的效果.护理研究,2016,30:1603-1606.
9 严红.临床路径在某医院医疗费用控制中的应用研究.华中科技大学硕士学位论文,2008.
10 徐淑娟.临床路径应用效果评价及影响因素调查分析.青岛大学硕士学位论文,2011.
